Glycostem to present at the business partnering event Advanced Therapy Showcase in Tokyo#1 on 21st January at 09.35 CET/17:35 GMT+9 with live streaming.

The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space. 

Glycostem to participate in SVB Leerink's Biopharma Private Company Connect from 15th to 17th December, 2020, though virtual one-on-one meeting.

Glycostem is invited to participate in the investor conference Stifel Virtual Healthcare Conference on 18^th November, 2020, 09:20AM (ET)/15:20PM (CET). Join the meeting through the link to meet our CEO Troels Jordansen.

Glycostem attends the 2nd Annual Cell & Gene Therapy Manufacturing conference virtually. Our CEO Troels Jordansen shares Glycostem world’s first off-the-shelf NK cell-based immunotherapy in the fight against cancer.

Glycostem participates the 7^th Solebury Trout Private Company Showcase co-hosted by BMO and Davis Polk. Glycostem CEO Troels Jordansen presents virtually on Thursday 15^th Oct 2020, with featured presentation and Q&A session.